Annovis Bio, Inc. (ANVS)

CIK 1477845 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Annovis Bio, Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 2026424B50001104659-26-123448
Nov 5, 20268-K0001104659-26-123467
Nov 4, 20268-K0001104659-26-122665
Nov 4, 2026424B50001104659-26-122761
Nov 4, 20268-K0001104659-26-122656
Oct 30, 20268-K0001104659-26-120732
Oct 20, 20268-K0001104659-26-116995
Oct 15, 2026SCHEDULE 13G/A0000919574-26-006984
Oct 7, 2026DEFA14A0001104659-26-114231
Sep 11, 2026DEF 14A0001104659-26-107113
Aug 25, 2026PRE 14A0001104659-26-100460
Aug 14, 20268-K0001104659-26-097091
Aug 14, 2026SCHEDULE 13G0000919574-26-005355
Aug 14, 202610-Q0001104659-26-097228
Jul 29, 2026SCHEDULE 13G0000919574-26-004667
Jul 10, 20268-K0001104659-26-082341
Jun 17, 20268-K0001104659-26-075198
May 21, 202640001104659-26-065311
May 20, 20268-K0001104659-26-064514
May 20, 2026424B50001104659-26-064510
May 19, 2026424B50001104659-26-063959
May 15, 20268-K0001104659-26-062451
May 15, 202610-Q0001104659-26-062626
Apr 30, 2026DEFA14A0001104659-26-053130
Apr 30, 2026DEF 14A0001104659-26-053096